Skip to main content

Table 4 Longitudinal comparison of KPS scores in the two groups

From: Effect of long-term adjuvant temozolomide chemotherapy on primary glioblastoma patient survival

KPS score

Group A(n = 27) Mean ± SD

Group B (n = 26)

Mean ± SD

P value

T1

79.62 ± 8.07

80.38 ± 12.15

0.792

T2

73.70 ± 6.87

73.46 ± 6.89

0.899

T3

91.11 ± 8.00

93.46 ± 6.89

0.257

T4

71.11 ± 21.89

89.61 ± 13.10

0.001